Congratulations to Dr. Fabian who was selected as the 2025-2026 ARRO Educator of the Year! This award is in honor of Dr. Fabian’s commitment to resident education and leadership promoting education as the residency program director. 🎉☢️👩🏼⚕️ #radonc@Deniskafab
Congratulations to Dr. Levy (@MLevyMDMPH) for continuing to serve as the National Communications Chair for the Society for Women in Radiation Oncology (@S_W_R_O) this year! ☢️🎉👩🏻⚕️
“We need a menopause revolution in this country. Better training is an obvious place to start. By including menopause care in both foundational and continuing education for health care practitioners, we can equip more of them to support their patients.”
Thank you @melindagates for your powerful words and investment for the future of menopause care in our country!
In radiation oncology, many patients experience abrupt, early onset menopause, as a direct result of their cancer treatment. Yet, education about radiation induced menopause is not a standard part of training. Without the proper education, it is impossible to provide guideline concordant care. This national cancer survivorship month is an important moment to raise awareness of this key educational opportunity.
Article: https://t.co/Jjr4xYn03u
@Deniskafab #gyncsm #survivorship
You can take the girl out of DC but you can't take DC out of the girl. So proud of our next gen and resident Dr Pierre Charles continuing with advocacy and education on the Hill. @ASTRO_org@drjpc_@RadoncUk@ARRO_org 🏆 🏅 👏
Out today, evaluating FAP immunoreactivity as a potential triage biomarker to identify women with uterine cervix cancer who may benefit from targeted radiopharmaceutical treatment. ☢️
Congrats to Dr. Fabian and Dr. Levy!
Link: https://t.co/0UBO3M9lpZ
@Deniskafab@MLevyMDMPH
Congratulations to Dr. Fabian who was been awarded a Markey Women Strong grant for 2026! This $50,000 grant is for work on “Patient-Centered Survivorship After Treatment-Induced Menopause: Hormone Therapy Experience and Bone Health Following Pelvic Radiation.” 1/2 @Deniskafab
“This study highlights a critical opportunity to strengthen survivorship care for cervical cancer patients, both in Kentucky and nationwide. Hormone therapy can meaningfully improve not only quality of life, but also long-term health.” - @Deniskafab
https://t.co/ObFVL0UUtJ
Would oncologists prescribe hormonal therapy after chemoradiotherapy for cervical cancer?
Out today in @JAMANetworkOpen, our survey through @SGO_org and @AmericanBrachy found that 93% of oncology clinicians would prescribe hormonal therapy but face barriers to implementation in practice.
Read the paper at: https://t.co/dViqQWzNc4
@Deniskafab@DrMarilynHuang #gyncsm
1/3
The 5th Annual DeMasi Lectureship was an excellent event honoring the legacy of Dr. DeMasi and to connect for education to advance the future of radiation oncology! Thank you to all who attended and presented especially our keynote speaker @DrEmmaHolliday. #radonc
Congratulations to our program director Dr. Fabian who was selected as program chair for the NRG Oncology Winter 2026 Educational Symposium, “Theranostics: Precision Imaging Meets Targeted Therapy,” during the NRG Oncology Winter Meeting! ☢️🎉 #radonc#NRG2026